- Home
- DDI vs PGEN Comparison
DDI vs PGEN Comparison
Compare DDI & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDI
- PGEN
- Stock Information
- Founded
- DDI 2008
- PGEN 1998
- Country
- DDI South Korea
- PGEN United States
- Employees
- DDI N/A
- PGEN N/A
- Industry
- DDI EDP Services
- PGEN Biotechnology: Pharmaceutical Preparations
- Sector
- DDI Technology
- PGEN Health Care
- Exchange
- DDI Nasdaq
- PGEN Nasdaq
- Market Cap
- DDI 472.2M
- PGEN 493.0M
- IPO Year
- DDI 2021
- PGEN N/A
- Fundamental
- Price
- DDI $9.15
- PGEN $3.28
- Analyst Decision
- DDI Strong Buy
- PGEN Buy
- Analyst Count
- DDI 5
- PGEN 5
- Target Price
- DDI $19.60
- PGEN $7.50
- AVG Volume (30 Days)
- DDI 45.3K
- PGEN 5.8M
- Earning Date
- DDI 11-10-2025
- PGEN 11-13-2025
- Dividend Yield
- DDI N/A
- PGEN N/A
- EPS Growth
- DDI N/A
- PGEN N/A
- EPS
- DDI 2.15
- PGEN N/A
- Revenue
- DDI $333,256,000.00
- PGEN $4,340,000.00
- Revenue This Year
- DDI $16.04
- PGEN $249.10
- Revenue Next Year
- DDI $6.72
- PGEN $710.03
- P/E Ratio
- DDI $4.31
- PGEN N/A
- Revenue Growth
- DDI 0.24
- PGEN N/A
- 52 Week Low
- DDI $8.09
- PGEN $0.65
- 52 Week High
- DDI $18.21
- PGEN $5.23
- Technical
- Relative Strength Index (RSI)
- DDI 40.75
- PGEN 46.00
- Support Level
- DDI $9.13
- PGEN $3.37
- Resistance Level
- DDI $9.45
- PGEN $4.00
- Average True Range (ATR)
- DDI 0.15
- PGEN 0.25
- MACD
- DDI -0.02
- PGEN -0.12
- Stochastic Oscillator
- DDI 18.20
- PGEN 21.08
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.